Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: Clinical and experimental studies

Michelle A. Rudek, Jürgen Venitz, Yuichi Ando, Eddie Reed, James M. Pluda, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Factors involved in the pharmacokinetics of COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer: Clinical and experimental studies'. Together they form a unique fingerprint.

Medicine & Life Sciences